Poor Tolerability of Lenvatinib in Elderly Patients with Advanced Hepatocellular Carcinoma after Disease Progression following First-Line Atezolizumab Plus Bevacizumab: A Multicenter Study.
Kato D, Suzuki T, Matsuura K, Okayama K, Okumura F, Nagura Y, Sobue S, Hayashi K, Kusakabe A, Hasegawa I, Matoya S, Mizoshita T, Kimura Y, Kondo H, Ozasa A, Kawamura H, Fujiwara K, Nojiri S, Kataoka H; Sakurayama Liver Study Group (SLSG).
Kato D, et al. Among authors: kondo h.
Oncology. 2024 Oct 18:1-9. doi: 10.1159/000541455. Online ahead of print.
Oncology. 2024.
PMID: 39427645